Skip to content
The Policy VaultThe Policy Vault

Votrient (pazopanib tablets) — Cigna

Renal Cell Cancer

Initial criteria

  • Patient age ≥ 18 years
  • Patient has relapsed or advanced disease OR patient has von Hippel-Lindau disease

Approval duration

1 year